Allosteric modulation of NMDA receptor via elevation of brain glycine and d-serine: The therapeutic potentials for schizophrenia
- 27 August 2008
- journal article
- review article
- Published by Elsevier BV in Pharmacology & Therapeutics
- Vol. 120 (3), 317-332
- https://doi.org/10.1016/j.pharmthera.2008.08.004
Abstract
No abstract availableThis publication has 157 references indexed in Scilit:
- Expression of D-serine and glycine transporters in the prefrontal cortex and cerebellum in schizophreniaSchizophrenia Research, 2008
- Increased brain d-amino acid oxidase (DAAO) activity in schizophreniaSchizophrenia Research, 2008
- Clinical lessons from the calcium-sensing receptorNature Clinical Practice Endocrinology & Metabolism, 2007
- A CSF and postmortem brain study of d-serine metabolic parameters in schizophreniaSchizophrenia Research, 2006
- Molecular determinants of D‐serine‐mediated gliotransmission: From release to functionGlia, 2006
- Glycine transporters: essential regulators of synaptic transmissionBiochemical Society Transactions, 2006
- Immunocytochemical analysis of D‐serine distribution in the mammalian brain reveals novel anatomical compartmentalizations in glia and neuronsGlia, 2005
- Modulation of NMDA receptors by glycine ? introduction to some basic aspects and recent developmentsAmino Acids, 1998
- Ligand affinities at recombinant receptors depend on subunit compositionEuropean Journal of Pharmacology: Molecular Pharmacology, 1994
- The effects of postnatal hyper- and hypothyroidism on the development of d-amino acid oxidase in rat cerebellum and brain stemBrain Research, 1977